Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Diagnosing Muscular Dystrophy

Clinical Presentation and Diagnosis

  • The American Academy of Neurology and the American Academy of Pediatrics recommend that children without family history be suspected of muscular dystrophy if they have delayed walking (>16-18 months), Gowers' sign, frequent falls, or difficulty running or climbing stairs 1, 3
  • In children with positive family history, any suspicion of abnormal muscle function should prompt investigation, according to the American Academy of Neurology 1
  • Unexplained elevated liver enzymes in a male child should raise suspicion for muscular dystrophy before proceeding to liver biopsy, as suggested by the American Association for the Study of Liver Diseases 1, 3
  • A waddling gait often accompanies Gowers' sign and increases suspicion for Duchenne muscular dystrophy (DMD), as noted by the American Academy of Pediatrics 2, 4

Diagnostic Testing

  • The American College of Medical Genetics recommends measuring serum creatine kinase (CK) levels as an initial screening test, which can be performed within the primary care setting 1, 5
  • If CK is elevated, the American Academy of Neurology suggests proceeding to genetic testing for dystrophin gene mutations 1, 2
  • Genetic testing should include multiplex PCR, multiplex ligation-dependent probe amplification, and single-condition amplification/internal hybridization, as recommended by the American College of Medical Genetics 2, 6

Post-Diagnosis Care

  • The American Academy of Pediatrics recommends referring patients to specialized multidisciplinary follow-up after diagnosis 1, 9
  • Genetic counseling should be provided for at-risk female family members, as suggested by the American College of Medical Genetics 1, 9
  • Patients and families should be connected with support organizations, such as the Muscular Dystrophy Association, as recommended by the American Academy of Neurology 1, 9

Clinical Assessment and Monitoring

  • Regular assessment of disease progression should include strength testing, range of motion, timed function tests, and activities of daily living assessment, as recommended by the American Academy of Neurology 7
  • Routine clinic appointments should be scheduled every 6 months, and specialist physical and occupational therapy assessments every 4 months, as suggested by the American Academy of Pediatrics 7